Amrize Ltd (NYSE:AMRZ – Get Free Report) CEO Jan Philipp Jenisch bought 21,417 shares of Amrize stock in a transaction that occurred on Friday, May 15th. The stock was bought at an average cost of $49.67 per share, for a total transaction of $1,063,782.39. Following the purchase, the chief executive officer owned 1,724,999 shares in the company, valued at $85,680,700.33. This represents a 1.26% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Jan Philipp Jenisch also recently made the following trade(s):
- On Friday, May 15th, Jan Philipp Jenisch bought 7,000 shares of Amrize stock. The stock was bought at an average cost of $49.12 per share, for a total transaction of $343,840.00.
- On Friday, March 6th, Jan Philipp Jenisch bought 60,000 shares of Amrize stock. The stock was bought at an average cost of $58.05 per share, for a total transaction of $3,483,000.00.
Amrize Price Performance
AMRZ stock traded up $0.69 on Monday, reaching $49.70. The company had a trading volume of 2,552,281 shares, compared to its average volume of 3,146,837. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $65.94. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The company’s fifty day moving average is $55.74 and its 200 day moving average is $55.18. The company has a market cap of $27.49 billion and a P/E ratio of 23.78.
Amrize Cuts Dividend
The business also recently announced a dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, May 12th. Amrize’s dividend payout ratio is presently 21.05%.
Analysts Set New Price Targets
A number of brokerages have weighed in on AMRZ. Wall Street Zen raised Amrize from a “sell” rating to a “hold” rating in a research note on Sunday, March 1st. Vertical Research raised Amrize from a “hold” rating to a “buy” rating and set a $70.00 price target on the stock in a research note on Friday, May 1st. Royal Bank Of Canada reduced their price target on Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Friday, May 1st. Stephens reissued an “overweight” rating and set a $65.00 price target on shares of Amrize in a research note on Monday. Finally, Truist Financial reduced their price target on Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Amrize currently has a consensus rating of “Moderate Buy” and a consensus target price of $64.86.
Get Our Latest Analysis on AMRZ
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the company. MCF Advisors LLC purchased a new position in shares of Amrize in the 4th quarter worth $27,000. State of Wyoming purchased a new position in shares of Amrize in the 3rd quarter worth $32,000. Basepoint Wealth LLC purchased a new position in shares of Amrize in the 4th quarter worth $33,000. Laurel Wealth Advisors LLC purchased a new position in shares of Amrize in the 4th quarter worth $34,000. Finally, US Bancorp DE purchased a new position in shares of Amrize in the 3rd quarter worth $38,000.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Further Reading
- Five stocks we like better than Amrize
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
